Am. J. Respir. Cell Mol. Biol.,
Volume 26, Number 3, March, 2002 306-314
Complementation of a Capsule Deficient Cryptococcus neoformans with
Cap64 Restores Virulence in a Murine Lung Infection
Julie A.
Wilder,
Gwyneth K.
Olson,
Yun C.
Chang,
Kyung J.
Kwon-Chung,
and
Mary F.
Lipscomb
University of New Mexico School of Medicine, Department of Pathology, Albuquerque, New Mexico; and Molecular Microbiology
Section, Laboratory of Clinical Investigation, NIAID, National Institutes of Health, Bethesda, Maryland
Cryptococcosis is a systemic infection in humans caused by
the opportunistic fungal pathogen, Cryptococcus neoformans.
The infection usually presents as chronic meningoencephalitis, but infects via the respiratory tract. A polysaccharide capsule is a major virulence factor, which allows the yeast to resist
host defenses. However, the essential role of the capsule in allowing it to resist host defenses during the initial lung infection has not been clearly shown. A mutant acapsular C. neoformans strain 602 was complemented with the CAP64 gene to
obtain an encapsulated strain, TYCC38-602. TYCC38-602 persisted in the lungs of C.B-17 mice after intratracheal inoculation and disseminated to the brain, whereas the mutant acapsular 602 and the plasmid control transformant CIP3-602
strains grew less readily in the lung and were infrequently detected in the brain. T cell-mediated immunity, developed to the encapsulated organism, was required to control growth
within the lungs and had a significant impact on numbers of
yeasts detected in the brain. The parent acapsular strain, but
not the transformant control, also required T cells for optimal
inhibition of growth within the lung, but not for maintaining
control of the colony-forming units (cfu) in the brain. In summary, the cryptococcal capsule plays an important role in lung
virulence and dissemination to the brain, and intact immunity
is required to control lung growth of the encapsulated yeast.
Abbreviations: analysis of variance, ANOVA; colony-forming units, cfu;
enzyme-linked immunosorbent assay, ELISA; fetal bovine serum, FBS;
Hanks' balanced salt solution, HBSS; interferon, IFN; interleukin, IL; inducible nitric oxide synthase, iNOS; lung-associated lymph node, LALN;
polymorphonuclear leukocyte, PMN; tumor necrosis factor- , TNF- ;
yeast extract peptone dextrose, YEPD.
This article has been cited by other articles:

|
 |

|
 |
 
V. Hernandez-Hansen, J. D. J. Bard, C. A. Tarleton, J. A. Wilder, C. A. Lowell, B. S. Wilson, and J. M. Oliver
Increased Expression of Genes Linked to Fc{epsilon}RI Signaling and to Cytokine and Chemokine Production in Lyn-Deficient Mast Cells
J. Immunol.,
December 15, 2005;
175(12):
7880 - 7888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nielsen, G. M. Cox, A. P. Litvintseva, E. Mylonakis, S. D. Malliaris, D. K. Benjamin Jr., S. S. Giles, T. G. Mitchell, A. Casadevall, J. R. Perfect, et al.
Cryptococcus neoformans {alpha} Strains Preferentially Disseminate to the Central Nervous System during Coinfection
Infect. Immun.,
August 1, 2005;
73(8):
4922 - 4933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Olszewski, M. C. Noverr, G.-H. Chen, G. B. Toews, G. M. Cox, J. R. Perfect, and G. B. Huffnagle
Urease Expression by Cryptococcus neoformans Promotes Microvascular Sequestration, Thereby Enhancing Central Nervous System Invasion
Am. J. Pathol.,
May 1, 2004;
164(5):
1761 - 1771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Noverr, P. R. Williamson, R. S. Fajardo, and G. B. Huffnagle
CNLAC1 Is Required for Extrapulmonary Dissemination of Cryptococcus neoformans but Not Pulmonary Persistence
Infect. Immun.,
March 1, 2004;
72(3):
1693 - 1699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Sommer, H. Liu, and T. L. Doering
An {alpha}-1,3-Mannosyltransferase of Cryptococcus neoformans
J. Biol. Chem.,
November 28, 2003;
278(48):
47724 - 47730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Ma and C. H. Mody
When There Is a Fungus Among Us, What Makes it Virulent?
Am. J. Respir. Cell Mol. Biol.,
March 1, 2002;
26(3):
273 - 276.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society.
|
|
|